# Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)

> **NCT04765592** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hangzhou Endonom Medtech Co., Ltd.** · enrollment: 88 (actual)

## Conditions studied

- Aortic Arch Aneurysm

## Interventions

- **DEVICE:** WeFlow-Arch Modeler Embedded Branch Stent Graft System

## Key facts

- **NCT ID:** NCT04765592
- **Lead sponsor:** Hangzhou Endonom Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-07
- **Primary completion:** 2025-02-05
- **Final completion:** 2029-02-05
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04765592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04765592, "Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04765592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*